AMZN
67
6
SRE
50
5
TROW
45
-3
JCI
30
-2
WMB
55
-3
CINF
50
-3
PRU
57
4
CHD
56
-2
APH
64
-4
PFG
46
-2
SLB
50
-10
RRC
45
-4
KLAC
63
-2
CRM
59
2
FLS
53
-4
ES
31
-3
PYPL
37
-2
WAT
37
4
RHI
37
-3
MAT
30
-9
AMZN
67
6
SRE
50
5
TROW
45
-3
JCI
30
-2
WMB
55
-3
CINF
50
-3
PRU
57
4
CHD
56
-2
APH
64
-4
PFG
46
-2
SLB
50
-10
RRC
45
-4
KLAC
63
-2
CRM
59
2
FLS
53
-4
ES
31
-3
PYPL
37
-2
WAT
37
4
RHI
37
-3
MAT
30
-9
Financhill
Back

Perspective Therapeutics Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
30

CATX
Perspective Therapeutics

Last Price:
9.88
Seasonality Move:
3.69%
Buy
53

SRPT
Sarepta Therapeutics

Last Price:
158.06
Seasonality Move:
18.65%
Sell
30
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $9.51. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
53
Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $156.91. The Score for SRPT is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
  • SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $9.51
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $156.91
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.38 Sell
Relative Strength Index (14 RSI): 33.33 Sell
Chaikin Money Flow: 1638221 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.78 - 14.58) Sell
Bollinger Bands (100): (9.9 - 15.82) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 7.17 Buy
Relative Strength Index (14 RSI): 68.43 Buy
Chaikin Money Flow: 1613298 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (113.82 - 142.64) Buy
Bollinger Bands (100): (118.8 - 136.1) Buy

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 10.38 Sell
20-day SMA: 12.03 Sell
50-day SMA: 14.61 Sell
200-day SMA: 8.17 Buy
8-day EMA: 10.47 Sell
20-day EMA: 11.89 Sell
50-day EMA: 13.1 Sell
200-day EMA: 9.9 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 140.03 Buy
20-day SMA: 129.22 Buy
50-day SMA: 127.95 Buy
200-day SMA: 115.45 Buy
8-day EMA: 145.32 Buy
20-day EMA: 134.79 Buy
50-day EMA: 129.39 Buy
200-day EMA: 120.67 Buy

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.05 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.18 per share, an increase next quarter of $2.65 per share, an increase this year of $6.58 per share, and an increase next year of $8.28 per share.

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):